BioInvent Enters Into Third Research Collaboration With University of Southampton

LUND, Sweden--(BUSINESS WIRE)--Regulatory News:

BioInvent International (STO:BINV) today announces a three-year research collaboration with the University of Southampton (UoS), one of the world’s leading antibody research groups, under the direction of Professor Mark Cragg, BSc, PhD, Professor of Experimental Cancer Research and Director of the Cancer Pathway Integrated Postgraduate Programme.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC